Mirae Asset Global Etfs Holdings Ltd. Amicus Therapeutics, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $39.6 Billion
- Q2 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 235,582 shares of FOLD stock, worth $2.59 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
235,582Holding current value
$2.59 Million% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding FOLD
# of Institutions
288Shares Held
321MCall Options Held
260KPut Options Held
261K-
Vanguard Group Inc Valley Forge, PA28.6MShares$314 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY28.1MShares$308 Million8.05% of portfolio
-
Avoro Capital Advisors LLC New York, NY27.4MShares$301 Million3.71% of portfolio
-
Black Rock Inc. New York, NY24.4MShares$268 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA21.1MShares$232 Million0.04% of portfolio
About AMICUS THERAPEUTICS, INC.
- Ticker FOLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 280,497,984
- Market Cap $3.08B
- Description
- Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...